MXPA03002875A - Composicion de vacuna y metodo de estabilizacion. - Google Patents
Composicion de vacuna y metodo de estabilizacion.Info
- Publication number
- MXPA03002875A MXPA03002875A MXPA03002875A MXPA03002875A MXPA03002875A MX PA03002875 A MXPA03002875 A MX PA03002875A MX PA03002875 A MXPA03002875 A MX PA03002875A MX PA03002875 A MXPA03002875 A MX PA03002875A MX PA03002875 A MXPA03002875 A MX PA03002875A
- Authority
- MX
- Mexico
- Prior art keywords
- vaccine composition
- stabilization method
- stabilization
- vaccine
- composition
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 230000006641 stabilisation Effects 0.000 title 1
- 238000011105 stabilization Methods 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0012805A FR2814957B1 (fr) | 2000-10-06 | 2000-10-06 | Composition vaccinale et procede de stabilisation |
| PCT/FR2001/003097 WO2002028362A2 (fr) | 2000-10-06 | 2001-10-08 | Composition vaccinale et procede de stabilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA03002875A true MXPA03002875A (es) | 2003-07-14 |
Family
ID=8855080
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA03002875A MXPA03002875A (es) | 2000-10-06 | 2001-10-08 | Composicion de vacuna y metodo de estabilizacion. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US6982088B2 (es) |
| EP (1) | EP1357895A2 (es) |
| JP (1) | JP2004526667A (es) |
| KR (1) | KR100832551B1 (es) |
| CN (1) | CN1298387C (es) |
| AU (2) | AU2001295672B2 (es) |
| BR (1) | BR0114350A (es) |
| CA (1) | CA2424863A1 (es) |
| FR (1) | FR2814957B1 (es) |
| MX (1) | MXPA03002875A (es) |
| NZ (1) | NZ525117A (es) |
| WO (1) | WO2002028362A2 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1951865A4 (en) * | 2005-11-21 | 2010-06-23 | Sanofi Pasteur Ltd | STABILIZING FORMULATIONS FOR RECOMBINANT VIRUSES |
| WO2012028315A1 (en) * | 2010-09-02 | 2012-03-08 | Sanofi Pasteur Sa | A stabilizer for the preparation of a dry polio injectable vaccine composition |
| IN2013MN02442A (es) | 2011-06-28 | 2015-06-12 | Inhibrx Llc | |
| PT2726092T (pt) | 2011-06-28 | 2019-10-08 | Lp Inhibrx | Polipéptidos de fusão serpina e métodos para a sua utilização |
| US10400029B2 (en) | 2011-06-28 | 2019-09-03 | Inhibrx, Lp | Serpin fusion polypeptides and methods of use thereof |
| US9827303B2 (en) * | 2012-03-05 | 2017-11-28 | De Staat Der Nederlanden, Vert. Door De Minister Van Vws, Ministerie Van Volksgezondheid, Welzijn En Sport | Methods and compositions for stabilizing dried biological materials |
| BR112015023205A2 (pt) * | 2013-03-14 | 2017-07-18 | Takeda Vaccines Inc | composições e métodos para formulações de alfavírus vivo atenuado |
| NL2018155B1 (en) * | 2017-01-11 | 2018-07-25 | Intervet Int Bv | Oral vaccine against ruminant respiratory disease |
| AU2020368656A1 (en) * | 2019-10-16 | 2022-04-21 | Janssen Vaccines & Prevention B.V. | Vaccine product |
| US20210322542A1 (en) * | 2020-04-11 | 2021-10-21 | Qiyi Xie | Vaccination against coronavirus with poliomyelitis vaccine |
| CN115697397A (zh) * | 2020-04-11 | 2023-02-03 | 谢七一 | 接种脊髓灰质炎疫苗对抗冠状病毒 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617350C3 (de) * | 1967-06-22 | 1979-09-06 | Behringwerke Ag, 3550 Marburg | Verfahren zur Inaktivierung von biologischem Material |
| US3919411A (en) * | 1972-01-31 | 1975-11-11 | Bayvet Corp | Injectable adjuvant and compositions including such adjuvant |
| US3915794A (en) * | 1973-02-09 | 1975-10-28 | Rit Rech Ind Therapeut | Stabilizing compositions for cell-free viruses and cell-free virus preparations containing them |
| US3915764A (en) * | 1973-05-18 | 1975-10-28 | Westinghouse Electric Corp | Sputtering method for growth of thin uniform layers of epitaxial semiconductive materials doped with impurities |
| ATE60999T1 (de) * | 1986-12-19 | 1991-03-15 | Duphar Int Res | Dimethyldioctadecylammoniumbromid enthaltende stabilisierte adjuvanssuspension. |
| US5709860A (en) * | 1991-07-25 | 1998-01-20 | Idec Pharmaceuticals Corporation | Induction of cytotoxic T-lymphocyte responses |
| CA2075521C (en) * | 1992-05-05 | 1995-11-28 | Kuniaki Koyama | Stabilized live vaccine |
| AU667003B2 (en) * | 1993-01-08 | 1996-02-29 | Csl Limited | Vaccine preparations |
| JPH09504429A (ja) * | 1993-10-12 | 1997-05-06 | チロン ビアジーン,インコーポレイティド | 組換えウイルスの保存方法 |
| US6379677B1 (en) * | 2000-02-25 | 2002-04-30 | The United States Of America As Represented By The Secretary Of The Department Of Agriculture | Streptococcus iniae vaccine |
-
2000
- 2000-10-06 FR FR0012805A patent/FR2814957B1/fr not_active Expired - Fee Related
-
2001
- 2001-10-08 WO PCT/FR2001/003097 patent/WO2002028362A2/fr not_active Ceased
- 2001-10-08 AU AU2001295672A patent/AU2001295672B2/en not_active Ceased
- 2001-10-08 JP JP2002531988A patent/JP2004526667A/ja active Pending
- 2001-10-08 BR BR0114350-6A patent/BR0114350A/pt not_active IP Right Cessation
- 2001-10-08 CN CNB018169708A patent/CN1298387C/zh not_active Expired - Fee Related
- 2001-10-08 NZ NZ525117A patent/NZ525117A/en unknown
- 2001-10-08 EP EP01976379A patent/EP1357895A2/fr not_active Withdrawn
- 2001-10-08 CA CA002424863A patent/CA2424863A1/en not_active Abandoned
- 2001-10-08 AU AU9567201A patent/AU9567201A/xx active Pending
- 2001-10-08 MX MXPA03002875A patent/MXPA03002875A/es active IP Right Grant
- 2001-10-08 KR KR1020037004927A patent/KR100832551B1/ko not_active Expired - Fee Related
- 2001-10-08 US US10/381,948 patent/US6982088B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20030190331A1 (en) | 2003-10-09 |
| US6982088B2 (en) | 2006-01-03 |
| BR0114350A (pt) | 2004-02-17 |
| WO2002028362A3 (fr) | 2003-09-12 |
| CA2424863A1 (en) | 2002-04-11 |
| AU9567201A (en) | 2002-04-15 |
| EP1357895A2 (fr) | 2003-11-05 |
| FR2814957A1 (fr) | 2002-04-12 |
| AU2001295672B2 (en) | 2005-08-18 |
| NZ525117A (en) | 2006-08-31 |
| JP2004526667A (ja) | 2004-09-02 |
| WO2002028362A2 (fr) | 2002-04-11 |
| CN1468091A (zh) | 2004-01-14 |
| KR100832551B1 (ko) | 2008-05-26 |
| FR2814957B1 (fr) | 2002-12-20 |
| CN1298387C (zh) | 2007-02-07 |
| KR20030096223A (ko) | 2003-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20026175L (no) | Vaksinesammensetning | |
| DE60118550D1 (de) | Neurotoxin implantat | |
| NO20024172L (no) | Vaksine | |
| ATE553775T1 (de) | Impstoffzusammesetzung | |
| DE60045324D1 (de) | Impfstoffzusammensetzung | |
| NO20004758L (no) | Vaksinesammensetning | |
| IS2932B (is) | Fúlvestrant samsetning | |
| DE60140246D1 (de) | Wärmende Zusammensetzung | |
| DE60139185D1 (de) | Vernetzbare perfluoroelastomarzusammensetzung | |
| GB0020089D0 (en) | Vaccine Composition | |
| NO20024890L (no) | Implantat | |
| FR2815535B1 (fr) | Implant pediculaire | |
| EP1284104A4 (en) | PASTEURIZER | |
| DK1265482T3 (da) | Vandige formulationer og fremgangsmåde til fremstilling af samme | |
| DE60125415D1 (de) | Formeinsatz | |
| NO20032122D0 (no) | Forbedret behandling | |
| NO20030239D0 (no) | Modifisert virus | |
| MXPA03002875A (es) | Composicion de vacuna y metodo de estabilizacion. | |
| CU23064A3 (es) | Conjunto implante dental-transportador | |
| DE10193450D2 (de) | Gehörschutzstöpsel | |
| DE50107204D1 (de) | 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate | |
| FR2817889B1 (fr) | Coffrage | |
| SE0003877D0 (sv) | New composition, method and use | |
| ES1046518Y (es) | Disposicion de bandera y similares. | |
| GB0006770D0 (en) | Vaccine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |